Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

One of the most common early signs of prostate cancer is trouble with urination. Urination is affected because the prostate ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

About one in eight men will be diagnosed with prostate cancer during their lifetime. Spotting and treating the cancer early can save lives. “If you’re going to find prostate cancer especially, the key ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

What you eat can affect your prostate health, for better or worse. Prostate-friendly foods can aid in recovery from prostate ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

And further detailed investigation confirmed he was suffering from metastatic prostate cancer—a condition in which the cancer ...

Prostate cancer tends to grow slowly. When caught in the earliest stages, the outlook is very good. The 5-year relative survival rate for prostate cancer that hasn’t spread, or has spread only ...

If prostate cancer recurs, follow-up treatment depends on what treatment you have already had, the extent of your cancer, the site of recurrence, other illnesses, your age, ...